Learn more

OBLIQUE THERAPEUTICS AB

Overview
  • Total Patents
    77
  • GoodIP Patent Rank
    18,966
  • Filing trend
    ⇧ 76.0%
About

OBLIQUE THERAPEUTICS AB has a total of 77 patent applications. It increased the IP activity by 76.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UCB Biopharma SRL, DEV CT BIOTECHNOLOGY and SAVID THERAPEUTICS INC.

Patent filings per year

Chart showing OBLIQUE THERAPEUTICS ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Orwar Owe 33
#2 Stafford William 28
#3 Pelcman Benjamin 28
#4 Trkulja Carolina 26
#5 Davidson Max 16
#6 Priede Martins 14
#7 Suna Edgars 14
#8 Owe Orwar 9
#9 Benjamin Pelcman 8
#10 Carolina Trkulja 8

Latest patents

Publication Filing date Title
GB202101780D0 Epitopes and Antibodies
GB202019522D0 Epitopes and antibodies
GB202002556D0 Epitopes and antobodies
GB201918103D0 Epitopes and antibodies
GB201918104D0 Epitopes and antibodies
WO2018146471A1 Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
US2020239417A1 Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
KR20190115011A Sulfinylpyridine and its use in the treatment of cancer
MX2019009351A Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer.
GB201617002D0 Multi-protease method
GB201614884D0 Method
WO2016193403A1 Electroporation device
US2018111990A1 New methods for epitope selection